Zundelevich A, Dadiani M, Kahana-Edwin S, Itay A, et al. ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast Cancer Res 2020;22:16.
PMID: 32014063